The Strengths and Limitations of ICP-MS Analysis
Inductively coupled plasma mass spectrometry (ICP-MS) is a flexible chemical analysis method that can be tailored to meet the demands of a wide variety of industries. In this article, we explore how it works, what it tells us, it's strengths and limitations and how it compares to other techniques in this analytical space.
What Could Cannabis Reform Look Like Under the Biden Administration?
A look to the next four years of cannabis policies under Joe Biden.
Canopy Growth’s Worm Study Finds CBD Is Safe for Long-Term Use
The Canadian cannabis giant's study suggests that lifelong CBD use is not only safe, it might just lengthen the average lifespan and increase activity levels in old age.
Unpacking the USDA’s Hemp Testing Framework
Why does hemp have to be reported on a dry-weight basis? What are the essential hemp testing procedures? Analytical Cannabis discusses the details of the USDA's hemp testing framework.
CBD Derivative Could Help Treat Huntington’s Disease and Rare Skin Diseases, Study Suggests
The CBD derivative molecule is an even more potent antioxidant and anti-inflammatory than CBD alone, the researchers claim.
California Awards Nearly $30 Million in Funding for Cannabis Research
California’s Bureau of Cannabis Control has awarded $29,950,494 in public university research grant funding to support cannabis-focused research projects in the state.
What Could Cannabis Legalization Look Like in New Jersey and South Dakota?
Several American states voted to legalize cannabis this November 2020. Will they succeed?
CBD is Not a Narcotic, EU Court Rules
The decision could have great implications for Europe’s CBD industry and how the EU Commission regulates hemp-derived cannabinoids.
Making Mushrooms: How Psilocybin Is Extracted and Used in Mental Health Research
Psilocybin’s emergence as a valuable tool for mental health research has been a huge breakthrough for the field. But how do researchers get their hands on this heavily regulated substance? We talked to Tim Moore, CEO of Havn Life Sciences, a company that produces psychoactive compounds from plants and fungi, to find out more.
